OMEMI 2014.

Trial name or title	OMega‐3 fatty acids in Elderly patients with Myocardial Infarction study (OMEMI)
Methods	RCT
Participants	Elderly patients (70‐82 years) with acute MI
Interventions	Each for 24 months: Arm 1: omega‐3 capsules, 3/d (Pikasol, total of 1.8 g/d EPA + DHA) and standard therapy Arm 2: corn oil placebo, 3/d and standard therapy
Outcomes	Primary: composite of total mortality, first non‐fatal recurring AMI, stroke and revascularisation Secondary: new onset atrial fibrillation, adipose tissue, serum fatty acids, makers of endothelial function, inflammation, coagulation and fibrinolytic activity, genes associated with atherothrombosis
Starting date	Registered on trials registry: 16 April 2013 Study start date: November 2012 Estimated study completion date: November 2019
Contact information	Svein Solheim, Center for Clinical Heart Research, Oslo University Hospital, arnljot.tveit@vestreviken.no
Notes	NCT01841944